Table 3 Factors related to the CT findings (multivariate analysis).
From: A multicenter study of CT findings in medication-related osteonecrosis of the jaw
Variable | Odds ratio | 95% CI | p value |
|---|---|---|---|
(i) Osteolysis (present/absent) | |||
Sort of ARA (BP vs. DMB) | 0.346 | 0.128–0.932 | 0.036 |
(ii) Sequestrum separation (present / absent) | |||
Age (years) | 1.033 | 1.008–1.058 | 0.008 |
Site (upper jaw vs. lower jaw) | 0.548 | 0.338–0.887 | 0.014 |
Primary disease (osteoporosis vs. ,malignant tumor) | 0.279 | 0.170–0.456 | < 0.001 |
Drug holiday (− vs. +) | 1.712 | 1.120–2.618 | 0.013 |
Duration of ARA administration (months) | 1.009 | 1.003–1.015 | 0.002 |
(iii) Periosteal reaction (present/absent) | |||
Steroid use (− vs. +) | 0.492 | 0.299–0.809 | 0.005 |
MRONJ stage (1 vs. 2 vs. 3) | 2.547 | 1.884–3.442 | < 0.001 |
Leukocytes (/µL/1000) | 0.898 | 0.825–0.977 | 0.012 |
Lymphocytes (/µL/1000) | 1.263 | 1.073–1.487 | 0.005 |
Serum albumin (mg/dL) | 0.619 | 0.418–0.917 | 0.017 |
(iv) Mixed-type osteosclerosis (present/absent) | |||
Site (upper jaw vs. lower jaw) | 2.656 | 1.570–4.492 | < 0.001 |
Primary disease (osteoporosis vs. ,malignant tumor) | 1.541 | 1.025–2.315 | 0.037 |
Lymphocytes (/µL / 1000) | 1.300 | 1.082–1.562 | 0.005 |
Serum albumin (mg/dL) | 0.656 | 0.448–0.959 | 0.030 |
(v) Bone within bone (present/absent) | |||
Drug holiday (- vs. +) | 4.533 | 1.258–16.334 | < 0.001 |
MRONJ stage (1 vs. 2 vs. 3) | 6.212 | 2.439–15.817 | < 0.001 |